Symbols

FBIO

Fortress Biotech·NASDAQ

--(--)

FBIO fundamentals

FBIO Q4 2025 Earnings Preview

Fortress Biotech (FBIO) expects to report earnings on Mar 31, 2026, with estimated revenue of 26.17M (YoY +73.08%), and EPS at 0.11 (YoY +164.71%).

Revenue estimate / YoY

26.17M

+73.08%

EPS estimate / YoY

0.11

+164.71%

Report date

Mar 31, 2026

Earnings

EPS

Revenue

Revenue & Expenses

FBIO has released its 2025 Q4 earnings report, with revenue of 16.08M, reflecting a YoY change of 6.34%, and net profit of -5.40M, showing a YoY change of 79.49%. The Sankey diagram below clearly presents FBIO's revenue sources and cost distribution.

Key Indicators

Fortress Biotech (FBIO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Fortress Biotech (FBIO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Fortress Biotech (FBIO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Fortress Biotech (FBIO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown